Oral administration of transforming growth factor-ß1 (TGF-ß1) protects the immature gut from injury via Smad protein-dependent suppression of epithelial nuclear factor ?B (NF-?B) signaling and proinflammatory cytokine production.

Oral administration of transforming growth factor-ß1 (TGF-ß1) protects the immature gut from injury via Smad protein-dependent suppression of epithelial nuclear factor ?B (NF-?B) signaling and proinflammatory cytokine production. J Biol Chem. 2013 Nov 29; 288(48):34757-66.

View in: PubMed

subject areas

Administration, Oral
Animals
Cell Line
Gastrointestinal Diseases
Humans
Immunity, Innate
Inflammation
Interferon-gamma
Interleukin-6
Interleukin-8
Intestinal Mucosa
NF-kappa B
Promoter Regions, Genetic
Rats
Signal Transduction
Smad Proteins
Smad2 Protein
Transforming Growth Factor beta1

authors with profiles

Erika C. Claud